Lyophilization Technology

Lyophilization Technology (LTI) specializes in contract development and manufacturing services focused on lyophilized healthcare products. The company has supported over 500 clients globally—including virtual biotech startups to large pharma—by developing formulations and processes for more than 900 different products over 25+ years. Its expertise spans product design/formulation development through pilot plant scale-up and US/EU-compliant clinical trial material production for biologics (up to BSL‑2), oncolytics, peptides/polypeptides/proteins/mAbs/liposomes/nanoparticles/vaccines/diagnostics/small molecules/highly potent compounds/device delivery systems. LTI’s facilities include advanced aseptic suites with containment/isolation technology suitable for cytotoxic/highly potent materials. The company does not have its own drug pipeline or proprietary therapies but acts as a key enabler for biotechs/pharmas developing injectable or freeze-dried medicines.